Measurement of serum CA 19-9 may be more valuable than CEA in prediction of recurrence in patients with gastric cancer.
American journal of clinical oncology, cilt.24, sa.2, ss.148-9, 2001 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 24 Sayı: 2
- Basım Tarihi: 2001
- Doi Numarası: 10.1097/00000421-200104000-00010
- Dergi Adı: American journal of clinical oncology
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.148-9
- İstanbul Üniversitesi Adresli: Evet
Özet
In 35 patients with recurrent gastric cancer who had undergone curative gastrectomy, serum carcinoembryonic antigen (CEA) and CA 19-9 (carbohydrate antigen) rumor marker levels were investigated. At least one tumor marker was elevated in 24 (68.6%) patients. The levels of serum CA 19-9 and CEA markers were increased in 20 (57.1%,) and 12(34.3%) patients, respectively. This difference was not statistically significant. However, it may be important in terms of clinical practice.